0.50
+24.53%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Pharma-Bio Serv
From its filings with the US Securities and Exchange Commission
Pharma-Bio Serv is based in Dorado, Puerto Rico. Its shares trade on OTC under the ticker PBSV. The SEC classifies its business as management consulting services. In the fiscal year to 31 October 2025, it reported revenue of $9.0m and a net loss of $100,463. At that date it held total assets of $13.7m and shareholders' equity of $11.9m. By region, Puerto Rico Consulting [Member] accounted for 51.5%, followed by United States Consulting [Member] at 29.1% and Europe Consulting [Member] at 19.2%.
We are a regulatory affairs, quality, compliance and technology transfer services consulting firm with headquarters in Puerto Rico, servicing the Puerto Rico, United States and European markets, and to a lesser extent the Brazilian market. The compliance consulting service sector in those markets consists of local compliance and validation consulting firms, United States dedicated validation and compliance consulting firms, and large publicly traded and private domestic and foreign engineering and consulting firms. We provide a broad range of compliance-related consulting services. We market our services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies principally in Puerto Rico, the United States, Europe and Brazil. Our consulting team includes experienced engineering and life science professionals, former quality assurance managers and directors, former health agency officials, and professionals with bachelors, masters and doctorate degrees in health sciences and engineering.
We have well-established and consistent relationships with the major pharmaceutical, biotechnology, medical device and chemical manufacturing companies in Puerto Rico and the United States, which provides us access to affiliated companies in other markets. We seek opportunities in markets that can yield profitable margins using our professional consulting force.
Quoted from its 10-K, filed 29 Jan 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 8 Nov 2008
- Employees
- 220
- Website
- pharmabioserv.com ↗
- Head office
- INDUSTRIAL ZONE STREET 1, DORADO, PR, 00646
- Classification
- Services-Management Consulting Services
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Kirk MichelIndependent Chairman of the Board$61,053
- Mr. Victor SanchezChief Executive Officer, President, President of European Operations$313,540
- Mr. Pedro LasantaChief Financial Officer, Vice President - Finance and Administration, Secretary$223,240
- Mr. Dov PerlyskyIndependent Director$61,053
- Mr. Howard SpindelIndependent Director$61,053
- Mr. Irving WiesenIndependent Director$61,053
- Mr. Scott GordonInvestor Relations, since 2022
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Pharma-Bio Serv Inc possesses several strengths that contribute to its success in the industry. These strengths include:
Weaknesses
- Despite its strengths, Pharma-Bio Serv Inc also faces certain weaknesses that could hinder its growth and competitive advantage. These weaknesses include:
Opportunities
- Pharma-Bio Serv Inc can capitalize on various opportunities to enhance its growth and market position. These opportunities include:
Threats
- Pharma-Bio Serv Inc faces certain threats that could impact its performance and market standing. These threats include:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.